These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8062513)
1. Effects of the neutral endopeptidase inhibitor, SCH 42495, on the cardiovascular remodelling secondary to chronic hypoxia in rats. Thompson JS; Sheedy W; Morice AH Clin Sci (Lond); 1994 Jul; 87(1):109-14. PubMed ID: 8062513 [TBL] [Abstract][Full Text] [Related]
2. Neutral endopeptidase (NEP) inhibition in rats with established pulmonary hypertension secondary to chronic hypoxia. Thompson JS; Sheedy W; Morice AH Br J Pharmacol; 1994 Dec; 113(4):1121-6. PubMed ID: 7889263 [TBL] [Abstract][Full Text] [Related]
3. Effects of SCH 34826, a neutral endopeptidase inhibitor, on hypoxic pulmonary vascular remodelling. Stewart AG; Sheedy W; Thompson JS; Morice AH Pulm Pharmacol; 1992 Jun; 5(2):111-4. PubMed ID: 1535251 [TBL] [Abstract][Full Text] [Related]
4. Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor. Zhao L; Hughes JM; Winter RJ Cardiovasc Res; 1994 Apr; 28(4):519-23. PubMed ID: 8181040 [TBL] [Abstract][Full Text] [Related]
5. Neutral endopeptidase inhibition attenuates development of hypoxic pulmonary hypertension in rats. Klinger JR; Petit RD; Warburton RR; Wrenn DS; Arnal F; Hill NS J Appl Physiol (1985); 1993 Oct; 75(4):1615-23. PubMed ID: 8282611 [TBL] [Abstract][Full Text] [Related]
6. Neutral endopeptidase 24.11 inhibition reduces pulmonary vascular remodeling in rats exposed to chronic hypoxia. Winter RJ; Zhao L; Krausz T; Hughes JM Am Rev Respir Dis; 1991 Dec; 144(6):1342-6. PubMed ID: 1835825 [TBL] [Abstract][Full Text] [Related]
7. Neutral endopeptidase inhibition increases the potency of ANP in isolated rat pulmonary resistance vessels and isolated blood perfused lungs. Thompson JS; Morice AH Pulm Pharmacol; 1995; 8(2-3):143-7. PubMed ID: 8820254 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats. Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451 [TBL] [Abstract][Full Text] [Related]
9. Neutral endopeptidase inhibitors and the pulmonary circulation. Thompson JS; Morice AH Gen Pharmacol; 1996 Jun; 27(4):581-5. PubMed ID: 8853287 [TBL] [Abstract][Full Text] [Related]
10. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733 [TBL] [Abstract][Full Text] [Related]
11. Effects of natriuretic peptides and neutral endopeptidase 24.11 inhibition in isolated perfused rat lung. Zhao L; Hughes JM; Winter RJ Am Rev Respir Dis; 1992 Nov; 146(5 Pt 1):1198-201. PubMed ID: 1443870 [TBL] [Abstract][Full Text] [Related]
12. Effects of SCH 42495, a neutral endopeptidase inhibitor, on cardiac function and mass in rats after repeated hyperbaric exposures. Stuhr LE Scand J Clin Lab Invest; 2000 Apr; 60(2):141-8. PubMed ID: 10817401 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of vasonatrin peptide against hypobaric hypoxia-induced pulmonary hypertension in rats. Yu J; Feng HS; Chen BY; Qu P; Liu LB; Chen JK; Tie R; Huang XJ; Zhao YF; Zhu XX; Zhu MZ Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):69-74. PubMed ID: 19566831 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495. Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202 [TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic factor-potentiating and antihypertensive activity of SCH 34826. An orally active neutral metalloendopeptidase inhibitor. Sybertz EJ; Chiu PJ; Vemulapalli S; Watkins R; Haslanger MF Hypertension; 1990 Feb; 15(2):152-61. PubMed ID: 2154404 [TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide levels in plasma and in cardiac tissues after chronic hypoxia in rats. Winter RJ; Meleagros L; Pervez S; Jamal H; Krausz T; Polak JM; Bloom SR Clin Sci (Lond); 1989 Jan; 76(1):95-101. PubMed ID: 2522033 [TBL] [Abstract][Full Text] [Related]
17. Regional plasma levels of cardiac peptides and their response to acute neutral endopeptidase inhibition in man. Lainchbury JG; Nicholls MG; Espiner EA; Ikram H; Yandle TG; Richards AM Clin Sci (Lond); 1998 Nov; 95(5):547-55. PubMed ID: 9791040 [TBL] [Abstract][Full Text] [Related]